- Home
- IMNM vs PNTG Comparison
IMNM vs PNTG Comparison
Compare IMNM & PNTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNM
- PNTG
- Stock Information
- Founded
- IMNM 2006
- PNTG 2019
- Country
- IMNM United States
- PNTG United States
- Employees
- IMNM N/A
- PNTG N/A
- Industry
- IMNM Medicinal Chemicals and Botanical Products
- PNTG Medical/Nursing Services
- Sector
- IMNM Health Care
- PNTG Health Care
- Exchange
- IMNM Nasdaq
- PNTG Nasdaq
- Market Cap
- IMNM 747.7M
- PNTG 1.1B
- IPO Year
- IMNM 2020
- PNTG N/A
- Fundamental
- Price
- IMNM $10.97
- PNTG $27.38
- Analyst Decision
- IMNM Strong Buy
- PNTG Buy
- Analyst Count
- IMNM 5
- PNTG 4
- Target Price
- IMNM $28.60
- PNTG $38.25
- AVG Volume (30 Days)
- IMNM 874.7K
- PNTG 222.3K
- Earning Date
- IMNM 11-13-2024
- PNTG 11-06-2024
- Dividend Yield
- IMNM N/A
- PNTG N/A
- EPS Growth
- IMNM N/A
- PNTG 62.21
- EPS
- IMNM N/A
- PNTG 0.68
- Revenue
- IMNM $10,129,000.00
- PNTG $652,302,000.00
- Revenue This Year
- IMNM N/A
- PNTG $29.15
- Revenue Next Year
- IMNM N/A
- PNTG $17.91
- P/E Ratio
- IMNM N/A
- PNTG $39.97
- Revenue Growth
- IMNM N/A
- PNTG 24.58
- 52 Week Low
- IMNM $8.33
- PNTG $13.77
- 52 Week High
- IMNM $30.96
- PNTG $37.13
- Technical
- Relative Strength Index (RSI)
- IMNM 39.61
- PNTG 28.94
- Support Level
- IMNM $10.76
- PNTG $29.29
- Resistance Level
- IMNM $15.13
- PNTG $29.62
- Average True Range (ATR)
- IMNM 0.98
- PNTG 1.04
- MACD
- IMNM -0.29
- PNTG -0.22
- Stochastic Oscillator
- IMNM 4.81
- PNTG 11.79
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which itcan efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious disease, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP) and and IM-4320.
About PNTG The Pennant Group Inc.
Pennant Group Inc is engaged in providing healthcare services to patients of all ages, including the growing senior population, in the United States. It operates in multiple lines of business including home health, hospice, and senior living which includes the company's assisted living, independent living, and memory care communities across Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The company generates majority of its revenue from home health and hospice services segment, which includes its home health, hospice and home care businesses.